Ballew Advisors’s Bausch Health BHC Stock Holding History

Ballew Advisors’s Portfolio BHC Stock Details BHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-4	Closed	–	–	115
2018 Q3	$0	Buy	+4	New	+$92	﹤0.01%	484

Other funds holding BHC

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

ValueAct Holdings San Francisco, California $5.71B AUM 7.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

GCM

Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

MVP

Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return

GAM

Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return

Ballew Advisors's BHC Position: Q4 2018 in Review

Ballew Advisors sold out of Bausch Health (BHC) in Q4 2018, closing a stake of 4 shares.

Ballew Advisors first reported a position in BHC in Q3 2018 and held it in 1 quarter. The position peaked at $0 in Q3 2018. 334 funds tracked by Wall St. Rank hold BHC as of Q4 2018.

Ballew Advisors reported no remaining Bausch Health position as of Q4 2018 after selling out during the quarter.
Ballew Advisors sold 4 Bausch Health shares in Q4 2018.
Ballew Advisors first reported a position in Bausch Health in Q3 2018 and held it in 1 quarter.
Ballew Advisors's Bausch Health position peaked at $0 in Q3 2018.
334 funds tracked by Wall St. Rank held Bausch Health as of Q4 2018.

Based on Ballew Advisors's 13F filing for Q4 2018, filed 12 Feb 2019.